The latest from TV, Radio, and Newspapers

Add a news source

Are we missing a Novato news source? Let us know!

Novato Newswire

Novato Newswire

Comprehensive Real-Time News Feed for Novato, CA.

Results 1 - 5 of 5 for "u:americanbankingnews.com" in Novato, CA

  1. Ultragenyx Pharmaceutical Inc. (RARE) Raised to Hold at Zacks Investment ResearchRead the original story w/Photo

    Jan 14, 2017 | AmericanBankingNews.com

    According to Zacks, "Ultragenyx Pharmaceutical Inc. is involved in the identification, acquisition, development and commercialization of products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. The Company's product pipeline include KRN23 for the treatment of XLH, rhGUS for the treatment of MPS 7, rhPPCA for the treatment of galactosialidosis, Triheptanoin for the treatment of LC-FAOD, Triheptanoin for the treatment of Glut1 DS and SA-ER for the treatment of HIBM which are in different clinical phases.

    Comment?

  2. Ultragenyx Pharmaceutical Inc. (RARE) Downgraded to Sell at Zacks Investment ResearchRead the original story w/Photo

    Jan 4, 2017 | AmericanBankingNews.com

    According to Zacks, "Ultragenyx Pharmaceutical Inc. is involved in the identification, acquisition, development and commercialization of products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. The Company's product pipeline include KRN23 for the treatment of XLH, rhGUS for the treatment of MPS 7, rhPPCA for the treatment of galactosialidosis, Triheptanoin for the treatment of LC-FAOD, Triheptanoin for the treatment of Glut1 DS and SA-ER for the treatment of HIBM which are in different clinical phases.

    Comment?

  3. Ultragenyx Pharmaceutical Inc. (RARE) Raised to Buy at Zacks Investment ResearchRead the original story w/Photo

    Oct 20, 2016 | AmericanBankingNews.com

    The brokerage presently has a $69.00 price target on the biopharmaceutical company's stock. Zacks Investment Research's price objective indicates a potential upside of 3.59% from the company's previous close.

    Comment?

  4. Ultragenyx Pharmaceutical Inc. (RARE) Stock Rating Upgraded by Zacks Investment ResearchRead the original story w/Photo

    Oct 20, 2016 | AmericanBankingNews.com

    The brokerage currently has a $69.00 price objective on the biopharmaceutical company's stock. Zacks Investment Research's price target points to a potential upside of 12.10% from the stock's current price.

    Comment?

  5. Recent Research Analysts' Ratings Updates for Ultragenyx PharmaceuticalRead the original story w/Photo

    Jun 28, 2016 | AmericanBankingNews.com

    They now have a $120.00 price target on the stock. 6/10/2016 - Ultragenyx Pharmaceutical had its "outperform" rating reaffirmed by analysts at Leerink Swann.

    Comment?

Novato Job Listings
View or post Novato job listings on Topix.
Novato Real Estate
News, listings, and foreclosures in Novato from Topix.
Novato Mortgages
Find mortgage rates in Novato on Topix.